Sahota Jeetender Singh
Type: individual
Citizenship: British
Age: 51
Owns & Controls
-
Individual
- 5 months
- 75%+
-
Resident of United Kingdom
-
Individual
- 1 year
- 25%+
-
Resident of United Kingdom
-
Individual
- 2 years
- 25%+
-
Resident of United Kingdom
-
Individual
- 4 years
- 25%+
-
Resident of United Kingdom
Manages
-
Individual
- 4 months
-
Resident of United Kingdom
-
Individual
- 5 months
-
Resident of United Kingdom
-
Individual
- 11 months
-
Resident of United Kingdom
-
Individual
- 1 year
-
Resident of United Kingdom
-
Individual
- 1 year
-
Resident of United Kingdom
Last changes
-
Chempharm LimitedTotal exemption full accounts made up to 2024-09-30Download pdf, 13 page(s) pdf report
-
Chempharm LimitedCompulsory strike-off action has been discontinuedDownload pdf, 1 page(s) pdf report
-
Chempharm LimitedConfirmation statement made on 2025-04-07 with no updatesDownload pdf, 3 page(s) pdf report
-
Warley Pharma LtdTotal exemption full accounts made up to 2024-09-30Download pdf, 12 page(s) pdf report
-
Chempharm LimitedFirst Gazette notice for compulsory strike-offDownload pdf, 1 page(s) pdf report
Co-directors of Sahota Jeetender Singh
Co-owners of Sahota Jeetender Singh
FAQ about Sahota Jeetender Singh
Looking for leads in the UK?
Try our FREE App—access UK datasets with limited features!
GDPR compliance
The data on this page is derived from the public records of Companies House and is processed by fully automated ML and AI algorithms. Please note that this data may contain errors. It is provided on an "as is" basis without any guarantees regarding completeness, accuracy, usefulness, or timeliness.
As per the guidance on personal data on the Companies House register, this personal data is exempt from certain data protection requirements. This is because the law mandates the public availability of this information. Other organisations, including ours, have the legal right to replicate information from the public register. For inquiries or concerns regarding data protection and privacy, please contact us at [email protected].